Cargando…
Perioperative administration of recombinant activated factor VII in a Glanzmannʼs thrombasthenia patient with platelet refractoriness: case report
Glanzmannʼs Trombasthenia (GT) is a genetic disorder, that develops with a tendency toward bleeding and is characterized by the absence or decrease in platelet aggregation. Surgical bleeding may be difficult to control. Platelet transfusion is the main treatment, albeit refractoriness can occur. We...
Autores principales: | Bisinotto, Flora Margarida Barra, Martins, Laura Bisinotto, de Camargos, Giovanini Pires, Bianco, Marcelo de Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683112/ https://www.ncbi.nlm.nih.gov/pubmed/34852265 http://dx.doi.org/10.1016/j.bjane.2021.09.021 |
Ejemplares similares
-
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
por: Poon, Man-Chiu
Publicado: (2021) -
The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status
por: Poon, Man-Chiu, et al.
Publicado: (2023) -
Glanzmann thrombasthenia
por: Nurden, Alan T
Publicado: (2006) -
The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia
por: Nurden, Alan T.
Publicado: (2023) -
Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia
por: Aliotta, Alessandro, et al.
Publicado: (2020)